Medtronic Q4 Adjusted EPS $1.57 Beats $1.56 Estimate, Sales $8.54B Beat $8.25B Estimate
Portfolio Pulse from Benzinga Newsdesk
Medtronic reported Q4 earnings of $1.57 per share, beating the analyst consensus estimate of $1.56. Quarterly sales reached $8.54 billion, surpassing the $8.25 billion estimate and marking a 5.62% increase YoY.
May 25, 2023 | 10:47 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Medtronic's Q4 earnings exceeded expectations with an EPS of $1.57 and sales of $8.54 billion, a 5.62% YoY increase.
Medtronic's Q4 earnings beat analyst estimates, with a 3.29% increase in EPS and a 5.62% increase in sales YoY. This positive financial performance is likely to have a short-term positive impact on the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100